Mixed lineage kinase 2 and hippocalcin are localized in Lewy bodies of Parkinson's disease
Authors:
- Masahiro NagaoMNMasahiro Nagao
- Hideaki HayashiHHHideaki Hayashi
- 1 June 2009
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 281 (1-2) , 51-54
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Regulation of axotomy‐induced dopaminergic neuron death and c‐Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinaseJournal of Neurochemistry, 2005
- Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase PathwayJournal of Neuroscience, 2005
- α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson diseaseNature Neuroscience, 2005
- Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybridsMolecular and Cellular Neuroscience, 2005
- Mixed lineage kinase–c‐jun N‐terminal kinase signaling pathway: A new therapeutic target in Parkinson's diseaseMovement Disorders, 2005
- The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PDNeurology, 2004
- Dynamics and calcium sensitivity of the Ca2+/myristoyl switch protein hippocalcin in living cellsJournal of Cell Biology, 2003
- Mixed-lineage kinase control of JNK and p38 MAPK pathwaysNature Reviews Molecular Cell Biology, 2002
- Autoinhibition of Mixed Lineage Kinase 3 through Its Src Homology 3 DomainJournal of Biological Chemistry, 2001
- Molecular cloning of hippocalcin, a novel calcium-binding protein of the recoverin family exclusively expressed in hippocampusBiochemical and Biophysical Research Communications, 1992